GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
- PMID: 15894280
- DOI: 10.1016/j.immuni.2005.03.013
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
Abstract
Indoleamine 2,3 dioxygenase (IDO) catabolizes the amino acid tryptophan. IDO-expressing immunoregulatory dendritic cells (DCs) have been implicated in settings including tumors, autoimmunity, and transplant tolerance. However, the downstream molecular mechanisms by which IDO functions to regulate T cell responses remain unknown. We now show that IDO-expressing plasmacytoid DCs activate the GCN2 kinase pathway in responding T cells. GCN2 is a stress-response kinase that is activated by elevations in uncharged tRNA. T cells with a targeted disruption of GCN2 were not susceptible to IDO-mediated suppression of proliferation in vitro. In vivo, proliferation of GCN2-knockout T cells was not inhibited by IDO-expressing DCs from tumor-draining lymph nodes. IDO induced profound anergy in responding wild-type T cells, but GCN2-knockout cells were refractory to IDO-induced anergy. We hypothesize that GCN2 acts as a molecular sensor in T cells, allowing them to detect and respond to conditions created by IDO.
Similar articles
-
Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.J Gene Med. 2005 May;7(5):565-75. doi: 10.1002/jgm.698. J Gene Med. 2005. PMID: 15543532
-
High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.J Cell Physiol. 2010 Oct;225(1):196-205. doi: 10.1002/jcp.22220. J Cell Physiol. 2010. PMID: 20648630
-
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.Int Immunol. 2005 Jul;17(7):909-19. doi: 10.1093/intimm/dxh271. Epub 2005 Jun 20. Int Immunol. 2005. PMID: 15967784
-
Tumor immune escape mediated by indoleamine 2,3-dioxygenase.Immunol Lett. 2007 Aug 15;111(2):69-75. doi: 10.1016/j.imlet.2007.06.001. Epub 2007 Jul 2. Immunol Lett. 2007. PMID: 17644189 Review.
-
Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Eur J Immunol. 2012 Aug;42(8):1932-7. doi: 10.1002/eji.201242572. Eur J Immunol. 2012. PMID: 22865044 Review.
Cited by
-
The roles of arginases and arginine in immunity.Nat Rev Immunol. 2024 Oct 17. doi: 10.1038/s41577-024-01098-2. Online ahead of print. Nat Rev Immunol. 2024. PMID: 39420221 Review.
-
TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3ζ.bioRxiv [Preprint]. 2024 Sep 24:2024.09.22.614388. doi: 10.1101/2024.09.22.614388. bioRxiv. 2024. PMID: 39386445 Free PMC article. Preprint.
-
General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases.Front Aging. 2024 Sep 10;5:1447370. doi: 10.3389/fragi.2024.1447370. eCollection 2024. Front Aging. 2024. PMID: 39319345 Free PMC article. Review.
-
Identification of amino acids metabolomic profiling in human plasma distinguishes lupus nephritis from systemic lupus erythematosus.Amino Acids. 2024 Sep 18;56(1):56. doi: 10.1007/s00726-024-03418-1. Amino Acids. 2024. PMID: 39292313 Free PMC article.
-
Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers.Cancers (Basel). 2024 Sep 5;16(17):3085. doi: 10.3390/cancers16173085. Cancers (Basel). 2024. PMID: 39272943 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials